Promedior
Latest round
- Series D
Last raised
- Feb 2012
Total raised
- $41M
Investors
- 6
About Promedior
Promedior Inc.Promedior Inc. is a biotechnology firm that specializes in developing therapies aimed at serious diseases. Established in 2006, the company is headquartered in Lexington, US.25 billion.Promedior Inc. is focused on developing innovative therapies for serious diseases, particularly in the fields of regenerative medicine and immune modulation. The company's portfolio includes therapeutic candidates that aim to address unmet medical needs, particularly in conditions that affect immune response and tissue regeneration.Promedior Inc. generates revenue through strategic partnerships and collaborations, particularly following its acquisition by Bristol-Myers Squibb Company.Following its acquisition by Bristol-Myers Squibb, Promedior Inc. aims to leverage its innovative therapies to expand its market reach. The recent acquisition deal, completed in August 2015, provides substantial financial resources that will be utilized to develop new products and enhance research initiatives. Plans include targeting new geographical markets to increase accessibility to its therapies, with a focus on key regions over the next few years, aligning with Bristol-Myers Squibb's strategic growth objectives.
Who invested in Promedior
6 investors across 3 rounds
See all investors in Promedior
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Promedior
Who invested in Promedior?
Promedior has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Promedior raised?
Promedior has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Promedior last raise money?
Promedior's most recent round on record is a Series D, in Feb 2012.
What does Promedior do?
Promedior is a biotechnology company.
Where is Promedior headquartered?
Promedior is headquartered in Lexington, US.
Which VCs invest in companies like Promedior?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Promedior's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Promedior? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.